These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1836917)
1. [New, in Austria registered specialty drugs. Zofran (Ondansetron, Glaxo)]. Erben M Wien Klin Wochenschr; 1991; 103(19):594-601. PubMed ID: 1836917 [No Abstract] [Full Text] [Related]
2. Ondansetron to prevent vomiting after cancer chemotherapy. Med Lett Drugs Ther; 1991 Jun; 33(847):63-4. PubMed ID: 1828531 [No Abstract] [Full Text] [Related]
3. Ondansetron to prevent chemotherapy-induced vomiting. Drug Ther Bull; 1992 Mar; 30(6):21-3. PubMed ID: 1534293 [No Abstract] [Full Text] [Related]
7. Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalan. Viner CV; Selby PJ; Zulian GB; Gore ME; Butcher ME; Wootton CM; McElwain TJ Cancer Chemother Pharmacol; 1990; 25(6):449-53. PubMed ID: 2138064 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs. McMillan C; Dundee JW; Abram WP Br J Cancer; 1991 Nov; 64(5):971-2. PubMed ID: 1834156 [No Abstract] [Full Text] [Related]
9. Freeze dried ondansetron: first observations with the fast dissolving oral antiemetic Zofran Zydis for the prophylaxis of the cisplatin-induced emesis in gynecological cancer patients. Lehoczky O; Udvary J; Pulay T Neoplasma; 2002; 49(2):126-8. PubMed ID: 12088106 [TBL] [Abstract][Full Text] [Related]
10. [Gastrointestinal toxicity induced by anticancer drugs--including new antiemetic drugs]. Sampi K; Taguchi T Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):922-8. PubMed ID: 2140498 [TBL] [Abstract][Full Text] [Related]
12. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes. Schmoll HJ Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S35-9. PubMed ID: 2533897 [TBL] [Abstract][Full Text] [Related]
13. Ondansetron: a new entity in emesis control. Graves T DICP; 1990 Nov; 24(11 Suppl):S51-4. PubMed ID: 2148659 [TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis]. Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810 [TBL] [Abstract][Full Text] [Related]
15. [Serotonin as mediator in vomiting reflex: effect of a serotonin3 receptor antagonist in chemotherapy-induced vomiting]. Layer P Z Gastroenterol; 1991 May; 29(5):265-6. PubMed ID: 1835227 [No Abstract] [Full Text] [Related]
16. Safety of ondansetron. Smith RN Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S47-50; discussion S51-4. PubMed ID: 2533899 [TBL] [Abstract][Full Text] [Related]
17. An overview of ondansetron for chemotherapy-induced nausea and emesis. San Angel F J Intraven Nurs; 1993; 16(2):84-9. PubMed ID: 8478782 [TBL] [Abstract][Full Text] [Related]
18. Ondansetron, a new antiemetic therapy for oncology. An overview. Lip H Scand J Gastroenterol Suppl; 1990; 178():55-61. PubMed ID: 2148983 [TBL] [Abstract][Full Text] [Related]
19. Clinical studies with ondansetron in the control of radiation-induced emesis. Priestman TJ Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S29-33. PubMed ID: 2533896 [TBL] [Abstract][Full Text] [Related]
20. [Curative effect of ondansetron on chemically-induced vomiting. Initial results]. Marty M; Le Bonniec M Presse Med; 1991 Jul 6-13; 20(26):1233. PubMed ID: 1831900 [No Abstract] [Full Text] [Related] [Next] [New Search]